STAT+: White House looks for more drug pricing deals to add to TrumpRx

WASHINGTON — After striking 16 deals with pharmaceutical giants and launching a direct-to-consumer drug purchasing platform, the Trump administration is looking to expand its efforts to lower drug  prices to more companies. 

Federal officials on Thursday unveiled the administration’s TrumpRx drug purchasing platform with 43 drugs, promising substantial discounts for people paying cash, without insurance. Continue to STAT+ to read the full story…